206 related articles for article (PubMed ID: 24023643)
1. Vaccination directed against the human endogenous retrovirus-K envelope protein inhibits tumor growth in a murine model system.
Kraus B; Fischer K; Büchner SM; Wels WS; Löwer R; Sliva K; Schnierle BS
PLoS One; 2013; 8(8):e72756. PubMed ID: 24023643
[TBL] [Abstract][Full Text] [Related]
2. Vaccination directed against the human endogenous retrovirus-K (HERV-K) gag protein slows HERV-K gag expressing cell growth in a murine model system.
Kraus B; Fischer K; Sliva K; Schnierle BS
Virol J; 2014 Mar; 11():58. PubMed ID: 24669861
[TBL] [Abstract][Full Text] [Related]
3. HIV-1 interacts with human endogenous retrovirus K (HML-2) envelopes derived from human primary lymphocytes.
Brinzevich D; Young GR; Sebra R; Ayllon J; Maio SM; Deikus G; Chen BK; Fernandez-Sesma A; Simon V; Mulder LC
J Virol; 2014 Jun; 88(11):6213-23. PubMed ID: 24648457
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxicity of human endogenous retrovirus K-specific T cells toward autologous ovarian cancer cells.
Rycaj K; Plummer JB; Yin B; Li M; Garza J; Radvanyi L; Ramondetta LM; Lin K; Johanning GL; Tang DG; Wang-Johanning F
Clin Cancer Res; 2015 Jan; 21(2):471-83. PubMed ID: 25370465
[TBL] [Abstract][Full Text] [Related]
5. Human endogenous retrovirus-K(II) envelope induction protects neurons during HIV/AIDS.
Bhat RK; Rudnick W; Antony JM; Maingat F; Ellestad KK; Wheatley BM; Tönjes RR; Power C
PLoS One; 2014; 9(7):e97984. PubMed ID: 24988390
[TBL] [Abstract][Full Text] [Related]
6. Human endogenous retroviruses and cancer prevention: evidence and prospects.
Cegolon L; Salata C; Weiderpass E; Vineis P; Palù G; Mastrangelo G
BMC Cancer; 2013 Jan; 13():4. PubMed ID: 23282240
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the human endogenous retrovirus K Gag protein: identification of protease cleavage sites.
Kraus B; Boller K; Reuter A; Schnierle BS
Retrovirology; 2011 Mar; 8():21. PubMed ID: 21429186
[TBL] [Abstract][Full Text] [Related]
8. Human endogenous retrovirus W family envelope gene activates the small conductance Ca2+-activated K+ channel in human neuroblastoma cells through CREB.
Li S; Liu ZC; Yin SJ; Chen YT; Yu HL; Zeng J; Zhang Q; Zhu F
Neuroscience; 2013 Sep; 247():164-74. PubMed ID: 23727510
[TBL] [Abstract][Full Text] [Related]
9. Oral vaccination with modified vaccinia virus Ankara attached covalently to TMPEG-modified cationic liposomes overcomes pre-existing poxvirus immunity from recombinant vaccinia immunization.
Naito T; Kaneko Y; Kozbor D
J Gen Virol; 2007 Jan; 88(Pt 1):61-70. PubMed ID: 17170437
[TBL] [Abstract][Full Text] [Related]
10. Immunotherapeutic potential of anti-human endogenous retrovirus-K envelope protein antibodies in targeting breast tumors.
Wang-Johanning F; Rycaj K; Plummer JB; Li M; Yin B; Frerich K; Garza JG; Shen J; Lin K; Yan P; Glynn SA; Dorsey TH; Hunt KK; Ambs S; Johanning GL
J Natl Cancer Inst; 2012 Feb; 104(3):189-210. PubMed ID: 22247020
[TBL] [Abstract][Full Text] [Related]
11. Human leukemia antigen-A*0201-restricted epitopes of human endogenous retrovirus W family envelope (HERV-W env) induce strong cytotoxic T lymphocyte responses.
Tu X; Li S; Zhao L; Xiao R; Wang X; Zhu F
Virol Sin; 2017 Aug; 32(4):280-289. PubMed ID: 28840564
[TBL] [Abstract][Full Text] [Related]
12. Infectious Entry Pathway Mediated by the Human Endogenous Retrovirus K Envelope Protein.
Robinson LR; Whelan SP
J Virol; 2016 Jan; 90(7):3640-9. PubMed ID: 26792739
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of Human Endogenous Retrovirus Type K (HERV-K) Viral
Li M; Radvanyi L; Yin B; Rycaj K; Li J; Chivukula R; Lin K; Lu Y; Shen J; Chang DZ; Li D; Johanning GL; Wang-Johanning F
Clin Cancer Res; 2017 Oct; 23(19):5892-5911. PubMed ID: 28679769
[No Abstract] [Full Text] [Related]
14. HERV-K-specific T cells eliminate diverse HIV-1/2 and SIV primary isolates.
Jones RB; Garrison KE; Mujib S; Mihajlovic V; Aidarus N; Hunter DV; Martin E; John VM; Zhan W; Faruk NF; Gyenes G; Sheppard NC; Priumboom-Brees IM; Goodwin DA; Chen L; Rieger M; Muscat-King S; Loudon PT; Stanley C; Holditch SJ; Wong JC; Clayton K; Duan E; Song H; Xu Y; SenGupta D; Tandon R; Sacha JB; Brockman MA; Benko E; Kovacs C; Nixon DF; Ostrowski MA
J Clin Invest; 2012 Dec; 122(12):4473-89. PubMed ID: 23143309
[TBL] [Abstract][Full Text] [Related]
15. An envelope glycoprotein of the human endogenous retrovirus HERV-W is expressed in the human placenta and fuses cells expressing the type D mammalian retrovirus receptor.
Blond JL; Lavillette D; Cheynet V; Bouton O; Oriol G; Chapel-Fernandes S; Mandrand B; Mallet F; Cosset FL
J Virol; 2000 Apr; 74(7):3321-9. PubMed ID: 10708449
[TBL] [Abstract][Full Text] [Related]
16. Human endogenous retrovirus envelope proteins target dendritic cells to suppress T-cell activation.
Hummel J; Kämmerer U; Müller N; Avota E; Schneider-Schaulies S
Eur J Immunol; 2015 Jun; 45(6):1748-59. PubMed ID: 25752285
[TBL] [Abstract][Full Text] [Related]
17. Expression of human endogenous retrovirus k envelope transcripts in human breast cancer.
Wang-Johanning F; Frost AR; Johanning GL; Khazaeli MB; LoBuglio AF; Shaw DR; Strong TV
Clin Cancer Res; 2001 Jun; 7(6):1553-60. PubMed ID: 11410490
[TBL] [Abstract][Full Text] [Related]
18. The HERV-K human endogenous retrovirus envelope protein antagonizes Tetherin antiviral activity.
Lemaître C; Harper F; Pierron G; Heidmann T; Dewannieux M
J Virol; 2014 Dec; 88(23):13626-37. PubMed ID: 25210194
[TBL] [Abstract][Full Text] [Related]
19. The envelope glycoprotein of human endogenous retrovirus HERV-W induces cellular resistance to spleen necrosis virus.
Ponferrada VG; Mauck BS; Wooley DP
Arch Virol; 2003 Apr; 148(4):659-75. PubMed ID: 12664292
[TBL] [Abstract][Full Text] [Related]
20. Expression of multiple human endogenous retrovirus surface envelope proteins in ovarian cancer.
Wang-Johanning F; Liu J; Rycaj K; Huang M; Tsai K; Rosen DG; Chen DT; Lu DW; Barnhart KF; Johanning GL
Int J Cancer; 2007 Jan; 120(1):81-90. PubMed ID: 17013901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]